COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down

Cooper Companies reported Q3 adjusted EPS of $1.15, beating estimates by 3.6%, but revenues of $1.066 billion missed expectations by 3.0%. CooperVision faced pressure from U.S. channel inventory reductions, while CooperSurgical showed resilience with 2% revenue growth. The stock fell 15.9% after-hours as management expects continued destocking headwinds in Q4, though underlying U.S. consumption remains healthy.